skip to main content

Dual antiplatelet and NSAID — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsDual antiplatelet and NSAIDGPhC CRA

A woman on aspirin and ticagrelor after coronary stenting asks for naproxen for back pain. She has previous gastric ulcer disease. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Avoid OTC naproxen and discuss safer analgesia

This scenario assesses Dual antiplatelet and NSAID in a UK pharmacy practice context. NSAIDs increase bleeding and gastrointestinal risk in patients receiving dual antiplatelet therapy. The best answer is Avoid OTC naproxen and discuss safer analgesia because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: BNF; NICE CKS